v3 Template
P

Pelage Pharmaceuticals

Biotechnology / Pharmaceuticals ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$136.8M
Funding Rounds
2
Last Funding
2025-10-15

About Pelage Pharmaceuticals

Pelage Pharmaceuticals is a company focused on developing regenerative medicines for hair loss, grounded in stem cell biology. Their mission is to deliver clinically-tested, FDA-approved treatments that target hair follicle stem cells to stimulate hair growth for all genders, skin types, and hair types, addressing conditions like androgenetic alopecia, drug-induced alopecia, and telogen effluvium.

Products & Services

PP405:A breakthrough topical, non-invasive small molecule treatment designed to reactivate dormant hair follicle stem cells, restoring hair growth in balding areas. It targets a metabolic switch in stem cells and is non-hormonal, suitable for all genders and hair types.

Specialties

Regenerative Medicine Stem Cell Biology Hair Loss Treatment Topical Drug Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B
A: 120000000
MR: -
FA: 120 million
FAN: 120000000
D: 2025-10-15
FD: 2025-10-15
5 investors
2 RT: Series A
T: -
FT: Series A
A: 16750000
MR: -
FA: 16.75M
FAN: 16750000
D: 2024-02-27
FD: 2024-02-27
4 investors
Series B Latest
2025-10-15
$120.0M
5 investors (Pro only)
Series A 2024-02-27
$16.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Daniel Gil

Chief Executive Officer

C

Christina Weng

Chief Medical Officer

N

Nathan Wheeler

Vice President, Head of Operations

W

William Lowry

President & Co-Founder

M

Mathew Avram

Director of the Dermatology Laser & Cosmetic Center, Massachusetts General Hospital Associate Professor of Dermatology, Harvard Medical School

A

Arash Mostaghimi

Vice Chair of Clinical Trials and Innovation, Director of the Dermatology Inpatient Service at Brigham & Women's Hospital, Associate Professor of Dermatology, Harvard Medical School

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Pelage Pharmaceuticals Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Pharmaceuticals
Company Size
~300 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro